SOLENO THERAPEUTICS INC (SLNO)

Latest Insider Confidence Score

2026Q1

49.2
Bearish

Company insider confidence (by quarter)

2014Q4 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Abingworth LLP 10% Owner 7,720,000 Mar 31, 2022
Forward V Associates LLC — 7,251,728 Mar 13, 2017
Forward Ventures V Lp — 7,251,728 Mar 13, 2017
Vivo Opportunity, LLC 10% Owner 4,458,294 Mar 28, 2025
Vivo Opportunity Fund Holdings, L.P. 10% Owner 4,458,294 Mar 28, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 2, 2026 Mar 4, 2026 Fulk Jennifer CFO Neutral 90.0 +39,200 100.00% ✗ -
Mar 4, 2026 Fulk Jennifer CFO Neutral 52.5 - 0.00% ✗ -
Jan 21, 2026 Jan 23, 2026 Yen Kristen Officer Neutral 90.0 +10,400 38.18% ✗ -
Jan 21, 2026 Jan 23, 2026 Norrett Kevin Chief Business Officer Neutral 90.0 +3,500 24.50% ✗ -
Jan 21, 2026 Jan 23, 2026 Manning Meredith Chief Commercial Officer Neutral 90.0 +28,600 65.85% ✗ -
Jan 21, 2026 Jan 23, 2026 Mackaness James H CFO Neutral 90.0 +28,600 27.72% ✗ -
Jan 21, 2026 Jan 23, 2026 Joshi Manher Chief Development Officer Neutral 90.0 +4,100 25.51% ✗ -
Jan 21, 2026 Jan 23, 2026 Huang Michael F. Sr. VP of Clinical Development Neutral 90.0 +10,400 28.88% ✗ -
Jan 21, 2026 Jan 23, 2026 Hirano Patricia C Officer Neutral 90.0 +10,400 84.54% ✗ -
Jan 21, 2026 Jan 23, 2026 Anish Bhatnagar CEO Neutral 90.0 +114,200 24.33% ✗ -
Dec 15, 2025 Dec 17, 2025 Yen Kristen Officer Sell 46.3 -904 -3.21% ✗ $45.2K
Dec 15, 2025 Dec 17, 2025 Manning Meredith Chief Commercial Officer Sell 42.5 -1,922 -4.24% ✗ $96K
Dec 15, 2025 Dec 17, 2025 Mackaness James H CFO Sell 42.5 -2,013 -1.91% ✗ $100.5K
Dec 15, 2025 Dec 17, 2025 Huang Michael F. Sr. VP of Clinical Development Sell 46.3 -812 -2.21% ✗ $40.6K
Dec 15, 2025 Dec 17, 2025 Hirano Patricia C Officer Sell 46.3 -904 -6.85% ✗ $45.2K
Dec 15, 2025 Dec 17, 2025 Anish Bhatnagar CEO Sell 40.0 -107,620 -18.65% ✗ $380.6K
Nov 17, 2025 Nov 19, 2025 Norrett Kevin Chief Business Officer Neutral 90.0 +14,286 100.00% ✗ -
Nov 19, 2025 Norrett Kevin Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Nov 10, 2025 Nov 12, 2025 Joshi Manher Chief Development Officer Neutral 90.0 +16,071 100.00% ✗ -
Nov 12, 2025 Joshi Manher Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Oct 13, 2025 Oct 14, 2025 Hahn Mark W Director Neutral 90.0 +10,046 100.00% ✗ -
Oct 14, 2025 Hahn Mark W Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 Jul 3, 2025 Hirano Patricia C Officer Sell 12.5 -3,830 -22.48% ✓ $317K
Jun 24, 2025 Jun 26, 2025 Hirano Patricia C Officer Sell 48.8 -266 -1.54% ✓ $22.4K
Jun 5, 2025 Jun 9, 2025 Volck Birgitte Director Neutral 90.0 +3,991 29.46% ✗ -
Jun 5, 2025 Jun 9, 2025 Sinclair Andrew Director Neutral 90.0 +3,991 61.40% ✗ -
Jun 5, 2025 Jun 9, 2025 Pauls Matthew Director Neutral 90.0 +3,991 61.40% ✗ -
Jun 5, 2025 Jun 9, 2025 Harris William G Director Neutral 90.0 +3,991 25.91% ✗ -
Jun 5, 2025 Jun 9, 2025 Bir Dawn Carter Director Neutral 90.0 +3,991 30.70% ✗ -
Apr 1, 2025 Apr 2, 2025 Hirano Patricia C Officer Sell 22.5 -3,782 -12.27% ✓ $265.2K
Mar 28, 2025 Mar 31, 2025 Pauls Matthew Director Sell 20.0 -5,937 -47.74% ✗ $424.8K
Mar 27, 2025 Mar 31, 2025 Yen Kristen Officer Sell 36.3 -95,500 -13.25% ✗ $6.4M
Mar 27, 2025 Mar 31, 2025 Manning Meredith Chief Commercial Officer Sell 37.5 -45,249 -9.53% ✗ $3M
Mar 27, 2025 Mar 31, 2025 Mackaness James H CFO Sell 36.3 -90,622 -6.70% ✗ $6.3M
Mar 27, 2025 Mar 31, 2025 Huang Michael F. Sr. VP of Clinical Development Sell 37.5 -14,583 -4.08% ✗ $1M
Mar 27, 2025 Mar 31, 2025 Hirano Patricia C Officer Sell 17.5 -156,315 -10.67% ✓ $10.7M
Mar 27, 2025 Mar 31, 2025 Anish Bhatnagar CEO Sell 35.0 -699,095 -7.86% ✗ $47.3M
Mar 26, 2025 Mar 28, 2025 Vivo Opportunity, LLC 10% Owner Sell 15.0 -1,833,557 -29.14% ✗ $124.4M
Jan 21, 2025 Jan 23, 2025 Yen Kristen Officer Neutral 85.0 +6,400 8.35% ✗ -
Jan 21, 2025 Jan 23, 2025 Manning Meredith Chief Commercial Officer Neutral 90.0 +13,600 34.00% ✗ -
Jan 21, 2025 Jan 23, 2025 Mackaness James H CFO Neutral 90.0 +14,500 13.03% ✗ -
Jan 21, 2025 Jan 23, 2025 Huang Michael F. Sr. VP of Clinical Development Neutral 90.0 +6,400 18.29% ✗ -
Jan 21, 2025 Jan 23, 2025 Hirano Patricia C Officer Neutral 85.0 +6,400 6.04% ✗ -
Jan 21, 2025 Jan 23, 2025 Anish Bhatnagar CEO Neutral 85.0 +53,900 7.72% ✗ -
Jan 2, 2025 Jan 6, 2025 Yen Kristen Officer Sell 42.5 -4,860 -5.97% ✗ $222.5K
Jan 2, 2025 Jan 6, 2025 Mackaness James H CFO Sell 40.0 -7,874 -6.61% ✗ $360.5K
Jan 2, 2025 Jan 6, 2025 Hirano Patricia C Officer Sell 42.5 -3,030 -2.78% ✗ $138.7K
Jan 2, 2025 Jan 6, 2025 Anish Bhatnagar CEO Sell 40.0 -21,091 -2.93% ✗ $965.5K
Oct 1, 2024 Oct 3, 2024 Yen Kristen Officer Sell 42.5 -3,108 -3.67% ✗ $153.6K
Oct 1, 2024 Oct 3, 2024 Mackaness James H CFO Sell 40.0 -8,077 -6.35% ✗ $399.2K
Oct 1, 2024 Oct 3, 2024 Hirano Patricia C Officer Sell 42.5 -3,108 -2.77% ✗ $153.6K
Oct 1, 2024 Oct 3, 2024 Anish Bhatnagar CEO Sell 37.5 -21,633 -2.92% ✗ $1.1M
Aug 28, 2024 Aug 30, 2024 Yen Kristen Officer Sell 40.0 -10,705 -11.24% ✗ $507.7K
Aug 28, 2024 Aug 30, 2024 Mackaness James H CFO Sell 40.0 -13,531 -9.61% ✗ $641.8K
Aug 28, 2024 Aug 30, 2024 Hirano Patricia C Officer Sell 40.0 -10,705 -8.72% ✗ $507.7K
Aug 28, 2024 Aug 30, 2024 Anish Bhatnagar CEO Sell 36.3 -115,004 -13.43% ✗ $5.5M
Aug 27, 2024 Aug 29, 2024 Vivo Opportunity, LLC 10% Owner Sell 15.0 -1,025,000 -14.01% ✗ $49.2M
Aug 13, 2024 Aug 23, 2024 Urbanski Raymond W. CHIEF DEVELOPMENT OFFICER Neutral 52.5 - 0.00% ✗ -
Aug 23, 2024 Urbanski Raymond W. CHIEF DEVELOPMENT OFFICER Neutral 52.5 - 0.00% ✗ -
Aug 15, 2024 Aug 16, 2024 Bir Dawn Carter Director Neutral 90.0 +13,000 100.00% ✗ -
Aug 16, 2024 Bir Dawn Carter Director Neutral 52.5 - 0.00% ✗ -
Aug 5, 2024 Aug 7, 2024 Yen Kristen Officer Sell 40.0 -10,974 -10.33% ✗ $500.4K
Aug 5, 2024 Aug 7, 2024 Mackaness James H CFO Sell 40.0 -14,983 -9.62% ✗ $683.2K
Aug 5, 2024 Aug 7, 2024 Hirano Patricia C Officer Sell 40.0 -11,009 -8.23% ✗ $502K
Aug 5, 2024 Aug 7, 2024 Anish Bhatnagar CEO Sell 36.3 -127,344 -12.95% ✗ $5.8M
Jul 17, 2024 Jul 19, 2024 Manning Meredith Chief Commercial Officer Neutral 90.0 +40,000 100.00% ✗ -
Jul 17, 2024 Jul 19, 2024 Huang Michael F. Sr. VP of Clinical Development Neutral 90.0 +35,000 100.00% ✗ -
Jul 17, 2024 Jul 19, 2024 Yen Kristen Officer Neutral 90.0 +85,000 399.96% ✗ -
Jul 17, 2024 Jul 19, 2024 Hirano Patricia C Officer Neutral 90.0 +85,000 174.34% ✗ -
Jul 17, 2024 Jul 19, 2024 Mackaness James H CFO Neutral 90.0 +100,000 179.33% ✗ -
Jul 17, 2024 Jul 19, 2024 Anish Bhatnagar CEO Neutral 90.0 +850,000 636.54% ✗ -
Jul 1, 2024 Jul 3, 2024 Yen Kristen Officer Sell 42.5 -2,170 -9.26% ✗ $90.1K
Jul 1, 2024 Jul 3, 2024 Mackaness James H CFO Sell 40.0 -7,190 -11.42% ✗ $298.7K
Jul 1, 2024 Jul 3, 2024 Hirano Patricia C Officer Sell 42.5 -2,170 -4.26% ✗ $90.1K
Jul 1, 2024 Jul 3, 2024 Anish Bhatnagar CEO Sell 40.0 -19,256 -12.60% ✗ $799.8K
Jun 6, 2024 Jun 10, 2024 Volck Birgitte Director Neutral 90.0 +6,500 92.26% ✗ -
Jun 6, 2024 Jun 10, 2024 Sinclair Andrew Director Neutral 90.0 +6,500 100.00% ✗ -
Jun 6, 2024 Jun 10, 2024 Pauls Matthew Director Neutral 90.0 +6,500 100.00% ✗ -
Jun 6, 2024 Jun 10, 2024 MARIO ERNEST Director Neutral 82.5 +6,500 3.12% ✗ -
Jun 6, 2024 Jun 10, 2024 Harris William G Director Neutral 90.0 +6,500 73.03% ✗ -
May 21, 2024 May 23, 2024 MARIO ERNEST Director Neutral 52.5 - 0.00% ✗ -
Apr 29, 2024 May 1, 2024 Vivo Opportunity, LLC 10% Owner Sell 15.0 -1,101,242 -13.08% ✗ $51.7M
Apr 30, 2024 Manning Meredith Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Apr 30, 2024 Huang Michael F. Sr. VP of Clinical Development Neutral 52.5 - 0.00% ✗ -
Apr 1, 2024 Apr 3, 2024 Yen Kristen Officer Sell 42.5 -2,218 -8.65% ✗ $91.7K
Apr 1, 2024 Apr 3, 2024 Mackaness James H CFO Sell 42.5 -5,175 -7.60% ✗ $213.9K
Apr 1, 2024 Apr 3, 2024 Hirano Patricia C Officer Sell 42.5 -2,218 -2.34% ✗ $91.7K
Apr 1, 2024 Apr 3, 2024 Anish Bhatnagar CEO Sell 40.0 -18,980 -11.05% ✗ $784.6K
Jan 25, 2024 Jan 29, 2024 Yen Kristen Officer Sell 46.3 -397 -1.52% ✗ $19.2K
Jan 25, 2024 Jan 29, 2024 Hirano Patricia C Officer Sell 46.3 -832 -1.89% ✗ $40.2K
Jan 25, 2024 Jan 29, 2024 Anish Bhatnagar CEO Sell 42.5 -2,527 -1.45% ✗ $122.1K
Jan 8, 2024 Jan 10, 2024 MARIO ERNEST Director Neutral 27.5 -3,523 -2.37% ✗ -
Jan 4, 2024 Jan 8, 2024 Yen Kristen Officer Neutral 90.0 +24,000 1178.20% ✗ -
Jan 4, 2024 Jan 8, 2024 Mackaness James H CFO Neutral 90.0 +56,000 461.74% ✗ -
Jan 4, 2024 Jan 8, 2024 Hirano Patricia C Officer Neutral 90.0 +24,000 120.16% ✗ -
Jan 4, 2024 Jan 8, 2024 Anish Bhatnagar CEO Neutral 90.0 +150,000 617.36% ✗ -
Dec 13, 2023 Dec 15, 2023 Hirano Patricia C Officer Sell 22.5 -6,244 -23.82% ✗ $239.1K
Dec 12, 2023 Dec 14, 2023 Yen Kristen Officer Sell 17.5 -37,829 -62.81% ✗ $1.4M
Dec 11, 2023 Dec 13, 2023 Anish Bhatnagar CEO Sell 17.5 -93,408 -79.36% ✗ $3.3M
Dec 11, 2023 Dec 13, 2023 Mackaness James H CFO Sell 17.5 -32,482 -72.81% ✗ $1.2M